A. Mesut Erzurumluoglu is a Principal Scientist in Bioinformatics at Bicycle Therapeutics, specializing in computational biology. He leverages large-scale human genetics and omics data for drug target identification and repurposing. He earned his PhD from the University of Bristol and has made significant contributions to pharmaceutical portfolio development.
Based on his shared content, he appears to have an interest in humanitarian topics, particularly the welfare of children affected by conflict. His professional interests include major pharmaceutical and technology companies that are shaping the future of medicine and data science.
Unique fact: While at Boehringer Ingelheim, he directly contributed to 27 drug targets that successfully entered the companys portfolio across four therapeutic areas.
Read the full overview →They are quite likely to negotiate on pricing or other key terms. They don’t appreciate bells and whistles unless backed by data. They choose to analyze logically and value facts to emotions.
Calculativeness (C) reflects the degree to which a person is likely to be cautious, systematic and analytical. Those scoring high tend to emphasise quality and accuracy.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.